These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 33584525

  • 21. Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers.
    Tassorelli C, Aguggia M, De Tommaso M, Geppetti P, Grazzi L, Pini LA, Sarchielli P, Tedeschi G, Martelletti P, Cortelli P.
    J Headache Pain; 2017 Dec; 18(1):66. PubMed ID: 28667550
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.
    Maasumi K, Thompson NR, Kriegler JS, Tepper SJ.
    Headache; 2015 Oct; 55(9):1218-24. PubMed ID: 26381856
    [Abstract] [Full Text] [Related]

  • 24. Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.
    Demiryurek BE, Ertem DH, Tekin A, Ceylan M, Aras YG, Gungen BD.
    Neurol Sci; 2016 Nov; 37(11):1779-1784. PubMed ID: 27418178
    [Abstract] [Full Text] [Related]

  • 25. Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.
    Ceccardi G, Schiano di Cola F, Caratozzolo S, Di Pasquale M, Bolchini M, Padovani A, Rao R.
    Toxins (Basel); 2023 Nov 30; 15(12):. PubMed ID: 38133181
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR, Lake AE, Tepper SJ.
    Headache; 2001 May 30; 41(5):465-74. PubMed ID: 11380644
    [Abstract] [Full Text] [Related]

  • 28. Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety.
    Corasaniti MT, Lawrence GW, Bagetta G, Iannacchero R, Tarsitano A, Monteleone A, Pagliaro M, Tonin P, Sandrini G, Nicotera P, Scuteri D.
    Front Pharmacol; 2023 May 30; 14():1296577. PubMed ID: 38152694
    [Abstract] [Full Text] [Related]

  • 29. Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17-30 months.
    Troy E, Shrukalla AA, Buture A, Conaty K, Macken E, Lonergan R, Melling J, Long N, Shaikh E, Birrane K, Tomkins EM, Goadsby PJ, Ruttledge MH.
    J Headache Pain; 2023 Jan 16; 24(1):5. PubMed ID: 36647006
    [Abstract] [Full Text] [Related]

  • 30. OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.
    Aydinlar EI, Dikmen PY, Kosak S, Kocaman AS.
    J Headache Pain; 2017 Dec 16; 18(1):23. PubMed ID: 28213829
    [Abstract] [Full Text] [Related]

  • 31. Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.
    Santoro A, Fontana A, Miscio AM, Zarrelli MM, Copetti M, Leone MA.
    Neurol Sci; 2017 Oct 16; 38(10):1779-1789. PubMed ID: 28726049
    [Abstract] [Full Text] [Related]

  • 32. [Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial].
    Artemenko AR, Abramov VG, Bozhenkina TV, Konovalova ZN, Korenko AN, Krasavina DA, Kurenkov AL, Latysheva NV, Naprienko MV, Orlova OR, Filatova EG, Shevchenko VS, Iakovleva PN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023 Oct 16; 123(11):64-74. PubMed ID: 37994890
    [Abstract] [Full Text] [Related]

  • 33. Subjective cognitive decline in patients with migraine and its relationship with depression, anxiety, and sleep quality.
    Lee SH, Kang Y, Cho SJ.
    J Headache Pain; 2017 Dec 16; 18(1):77. PubMed ID: 28744704
    [Abstract] [Full Text] [Related]

  • 34. Onabotulinumtoxin A (BOTOX®) for ProphylaCTIC Treatment of Pediatric Migraine: A Retrospective Longitudinal Analysis.
    Shah S, Calderon MD, Wu W, Grant J, Rinehart J.
    J Child Neurol; 2018 Aug 16; 33(9):580-586. PubMed ID: 29877131
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
    Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ.
    Headache; 2020 Oct 16; 60(9):1910-1919. PubMed ID: 32749685
    [Abstract] [Full Text] [Related]

  • 37. Photophobia is associated with lower sleep quality in individuals with migraine: results from the American Registry for Migraine Research (ARMR).
    Sharp N, Burish MJ, Digre KB, Ailani J, Fani M, Lamp S, Schwedt TJ.
    J Headache Pain; 2024 Apr 12; 25(1):55. PubMed ID: 38609895
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The relationships between migraine, depression, anxiety, stress, and sleep disturbances.
    Yalinay Dikmen P, Yavuz BG, Aydinlar EI.
    Acta Neurol Belg; 2015 Jun 12; 115(2):117-22. PubMed ID: 24889393
    [Abstract] [Full Text] [Related]

  • 40. Psychological factors and biochemical indicators influencing sleep disturbance of patients with primary biliary cholangitis in China: a cross-sectional survey analysis.
    Zhao C, Zang B, Liu Q, Liu B, Yao Y, Li H, Yang Y, Liu B.
    Front Med (Lausanne); 2024 Jun 12; 11():1444473. PubMed ID: 39430587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.